174 results about "Injected drug" patented technology

The present invention is a system and method of pre-delivery drug identification. The system and method is implemented where drugs are being administered, such as in a hospital or clinic, and identifies the drug being administered to the patient before the drug reaches the patient. The system and method may utilize a sensor used for other physiologic monitoring to identify the drug. After identification, the system and method is configured to cross-reference the identified drug with the patient's prescription and allergy information, and to prevent delivery to the patient, if necessary. The system and method also utilizes data collected from the patient with a physiological monitor or a ventilator sensor to further determine whether the drug is appropriate for the patient. The method and system may also include an override system for medical personnel. The method described may be carried out by a software application.

An article of manufacture is provided comprising a vial having (a) a first chamber that is substantially filled with an injectable pharmaceutical formulation; (b) a second chamber that is substantially empty but for a gaseous medium; (c) a septum, impermeable to the gaseous medium, separating the first and second chambers; and (d) actuating means effective to bring the formulation and the gaseous medium into contact by breach of the septum such that the gaseous medium acts as an effective headspace for agitation of the formulation. The formulation comprises an aqueous medium, a drug in solid particulate form in a therapeutically effective amount suspended in the medium, and one or more wetting and / or suspending agents in an amount effective to provide controlled flocculation of the drug, at least one ingredient of the formulation being susceptible to oxidative degradation.

Compositions may include a pharmaceutical active agent, a high viscosity liquid carrier material (HVLCM), a lactic acid-based polymer, and an organic solvent. Related compositions and methods are also disclosed. For instance, a carrier formulation for controlled release of injectable drugs is disclosed. The formulation may include a non-water soluble high viscosity liquid which may be sucrose acetate isobutyrate, a lactic-acid based polymer which may be a poly(lactic acid)(glycolic acid), and an organic solvent which maintains the composition in a monophasic form at 25° C. in one atmosphere. Drug in the formulation may be released upon administration such that less than 10% (e.g. 2-8%) of drug is released in the first 5 hours; 10% to 80% of the drug is released during a period of 5 hours to 7 days after administration; and 10% to 40% of the drug is released gradually over a period of 7 days to 28 days from initial administration. The drug may be an anti-schizophrenia agent delivered by injection.

The invention discloses insulin providing liquid agent through nose, which is characterized by the following: avoiding side-effect due to injecting drug, increasing drug adsorbing area because the nose possesses bigger nasal area (150-180cm<2>) with large scale of microvillus and thinner nasal mucosa (2-4mm), adsorbing drug rapidly due to abundant capillary and capillary lymphangiolog.

The present invention relates to injectable pharmaceutical compositions showing improved storage stability said compositions comprising adrenaline and citric acid showing improved storage stability.

The invention relates to a photosensitizer and its preparation method and application. The photosensitizer is a liposome preparation composed of phthalocyanine zinc complex. The liposome preparation can be uniformly dispersed in an aqueous solution and exists stably for a long time, so it can be conveniently used as an injection drug, has high targeting, and can better exert drug effects. At the same time, the preparation has a wide range of killing and inhibiting effects on various types of bacteria, and has a strong killing effect on various cancer cells. item requirements.

The invention discloses a rapid bloating-relieving and digestion-promoting device for treating bloating in rumen and belongs to the technical field of veterinary apparatuses and instruments. The rapid bloating-relieving and digestion-promoting device is capable of taking both drug injection and bloating-relieving into account, and also capable of effectively and mechanically breaking bubbles in the rumen while injecting drugs and preventing chyme attached on the bubbles from blocking a bloating-relieving channel; while injecting drugs, the rotating speed of a drug injection part can be controlled manually, and meanwhile, drugs can be injected into the rumen at a large area and in all directions; the device is further provided with a sucking pump and a cardiac rhythm tester; the pressure in the rumen and the heart conditions of a silk animal can be monitored in real time during an operation, the pressure in the rumen can be reduced in real time quickly and the heart conditions of the silk animal can be monitored in real time during the operation, and complications during the operation can be prevented; furthermore, the device is provided with a massager which is capable of helping bloating-relieving during the operation and postoperative recovery.

A drug delivery system for injecting a medicament is provided. The system includes a container configured to receive a medicament; a drive assembly which, upon actuation, is configured to expel the medicament from the container; a needle for injecting the medicament to a patient; a fluid path assembly comprising a tube in fluid communication with the container and the needle for conducting fluid from the container to the needle; and a tube crimping arrangement configured to engage the tube to block fluid flow through the tube. The drive assembly causes the tube crimping arrangement to engage the tube after a dose of the medicament has been delivered to the patient through the needle.

A therapeutic treatment device, system and method for improving administration of a temperature sensitive drug into a tissue on the body of a patient at a drug injection site are disclosed. The device includes a treatment element with a controllable heating element in temperature communicative contact with the tissue adjacent to the drug injection site. The controllable heating element is configured to heat the tissue adjacent to the drug injection site to a controllable temperature but does not heat the injected drug above a predetermined limiting temperature, above which degradation of the injected drug may occur.

The present invention relates to a skull implant type drug injection port comprising: a holder which is placed on the upper section of a port insertion hole formed in the skull of a patient and has a drug injection hole formed on the upper surface thereof; a drug injection diaphragm which is provided so as to seal the drug injection hole of the holder and into which a syringe needle for injecting a drug is inserted; a drug storage part combined with the lower section of the holder, for storing the drug inserted through the drug injection diaphragm; a drug discharge pipe which is connected to the drug storage part so as to discharge the drug stored in the drug storage part; and a rib which is formed on the outskirt between the holder and the drug storage part and has a diameter larger than the inner diameter of the port insertion hole, wherein the height ratio of the holder to the drug storage part is 1:0.5 to 0.6 on the basis of the rib. The present invention relates to a skull implant type drug injection system comprising: a skull implant type drug injection port; and a guide needle which is attachable to and detachable from the drug discharge pipe by passing through the drug injection diaphragm of the skull implant type drug injection part, wherein the guide needle has a protruding section formed on an area which is separated at a predetermined distance from a cutting-edge section.

The invention concerns a device for injecting a solid medicine (10) comprising a body (2) inside which moves along a general forward moving axis (X-X) a bevelled (34) needle (4) wherein is introduced the medicine (10), said injection device (1) further comprising retaining means for preventing the medicine from falling (10) prior to being injected. The invention is characterized in that the medicine (10) is retained through an elastic deformation imparted to the needle (4) by the retaining means or by an elastic deformation of the retaining means themselves, or still by the combined flexibility of those two means.

A drug delivery system for injecting a medicament includes a housing defining a cavity, a container received within the cavity and configured to receive a medicament, the container comprising a stopper configured to move within the container and a closure, a drive assembly received within the cavity and configured to drive the stopper within the container, a needle actuator assembly received within the cavity and comprising a needle configured to be placed in fluid communication with the container, the needle moveable from a first position and a second position spaced from the first position, and a sterilizer received within the cavity and configured to sterilize at least one of the container, the drive assembly, and the needle actuator assembly upon activation of the drug delivery system.

A drug delivery system for injecting a medicament includes a container including a closure and a stopper configured to move within the container from a pre-use position to a post-use position. The system includes a drive assembly configured to move the stopper between first and second positions, and a spacer assembly engaged with the stopper configured to be engaged by the drive assembly. The spacer assembly includes a first spacer portion received within the stopper, a second spacer portion spaced from the first spacer portion, an inner plunger, and a spacer shuttle received by the inner plunger. The inner plunger, the spacer shuttle, and the second portion are configured to move relative to the stopper, where movement of the second spacer portion is restricted by the spacer shuttle, movement of the spacer shuttle is restricted by the inner plunger, and movement of the inner plunger is restricted by the stopper.